Yellow eyes after gallbladder surgery.

Jaundice in the general population is common and has many causes — hepatitis, cirrhosis, certain medications, hereditary conditions like Gilbert's syndrome. The medical default in a random walk-in patient might reasonably be a broad differential and an ordered workup. The medical default in a patient who had a laparoscopic cholecystectomy three days or three weeks ago is entirely different. Post-operative jaundice in a post-cholecystectomy patient carries a presumption of biliary-tract origin until imaging proves otherwise.

The reason is structural. Laparoscopic cholecystectomy is a technically demanding operation performed in a small anatomical window — the triangle of Calot — where the common bile duct, common hepatic duct, cystic duct, and right hepatic artery converge within a few centimeters of each other. The SAGES Safe Cholecystectomy Program exists precisely because this operation carries a small but persistent rate of ductal misidentification, with the classic error being a surgeon mistaking the common bile duct for the cystic duct and clipping, cutting, or transecting it before the mistake is recognized. Across most published series the bile duct injury rate sits in roughly the 0.3-0.6% range for laparoscopic cases — a small percentage of an enormous number of annual procedures.

Jaundice in this population is therefore a signal, not a symptom to be reassured away. The clinical default in every major hepatobiliary textbook is to work up post-operative jaundice aggressively, rule out biliary injury and leak first, and only then consider the broader differential. A surgeon who examines a jaundiced post-op patient and sends them home with reassurance and no imaging has deviated from the accepted standard of care in most documented malpractice reviews of delayed-recognition cases.

This spoke is meant to give patients and families a framework for what that workup should look like, what the timeline of recognition should feel like, and why the window between early recognition and late recognition carries such weight — both for recovery and, when negligence is involved, for the case.

Jaundice is yellowing of the tissues caused by elevated serum bilirubin. In practice, the first place it appears is the sclerae — the whites of the eyes. This is called scleral icterus. It becomes visible when total serum bilirubin exceeds roughly 2.5-3.0 mg/dL, though the exact threshold varies by lighting, skin tone, and observer experience. The yellow deepens as bilirubin climbs further. By the time skin yellowing is obvious across the face and chest, bilirubin is typically well above 5 mg/dL.

In patients with darker skin tones, scleral icterus may be more subtle on first examination but is still the earliest visible sign. The examination should be done in natural daylight whenever possible, with the patient looking upward so the lower sclerae are exposed. Self-examination in a bathroom mirror under fluorescent light is notoriously unreliable. This is why family members or friends often notice post-op jaundice first — and why patient complaints of "my wife says my eyes look yellow" should never be dismissed.

Other signs accompanying jaundice include darker urine (the tea-colored or cola-colored urine of conjugated bilirubin spilling into the kidney), lighter stools (acholic or clay-colored, from absent bile pigment reaching the gut), and generalized itching (pruritus) as bile salts accumulate in the skin. Malaise, fatigue, and mild nausea often accompany the rise in bilirubin and can be mistaken for lingering post-operative symptoms.

The timeline of appearance matters. In a complete obstruction — a clipped or transected common bile duct — jaundice typically becomes visible within 48-96 hours. In a partial injury, a slipped clip on the cystic duct stump, or a thermally damaged duct that has not yet retracted, jaundice may not appear for one to three weeks and may fluctuate as the pattern of obstruction changes. Either presentation is a clinical red flag. Neither one is benign.

Post-cholecystectomy jaundice has a narrow, well-characterized differential diagnosis. In most hepatobiliary series, three causes account for the overwhelming majority of presentations.

The first is a retained common bile duct stone. During gallbladder dissection, small stones can slip out of the gallbladder neck or cystic duct and migrate into the common bile duct, where they obstruct bile flow and cause obstructive jaundice. Retained stones are often identified on pre-operative imaging or intraoperative cholangiography; when they are missed, they declare themselves in the days to weeks after surgery with jaundice, right-upper-quadrant pain, and sometimes cholangitis. Management is typically ERCP with stone extraction.

The second is a bile duct injury. This is the category that drives most malpractice litigation. Injuries include complete transections, clips placed across the common bile duct or common hepatic duct, thermal injuries from electrocautery, and partial tears. The presentation varies with injury type — complete obstructions produce progressive jaundice, partial injuries fluctuate, and leaks may present with biloma and peritonitis before jaundice declares. Strasberg classification (covered in its own section below) grades severity from Type A through E5.

The third is a bile leak with developing ascending cholangitis. A leak from the cystic duct stump, a duct of Luschka, or a small partial injury to the main bile duct allows bile to accumulate in the peritoneal cavity. Bacterial translocation from the gut colonizes the bile, and ascending cholangitis develops — producing Charcot's triad (right-upper-quadrant pain, fever with chills, jaundice) and sometimes progressing to Reynolds' pentad with hypotension and altered mental status.

Less common causes to rule out include post-operative pancreatitis with compression of the distal bile duct, hemobilia (bleeding into the biliary tree from a liver laceration or injury to the right hepatic artery), drug-induced hepatotoxicity from anesthetic or antibiotic agents, and underlying hepatocellular disease unmasked by the stress of surgery. Each of these is a diagnosis of exclusion — confirmed only after biliary imaging has ruled out the big three.

The laboratory workup for post-operative jaundice is straightforward, inexpensive, and available in every emergency department and most outpatient clinics. The core panel is comprehensive metabolic panel plus liver function tests — total bilirubin, direct (conjugated) bilirubin, AST, ALT, alkaline phosphatase, and gamma-glutamyl transferase (GGT). A complete blood count adds context, especially white blood cell count for possible cholangitis. Lipase and amylase are added when pancreatitis is on the differential.

The bilirubin pattern is the first thing to read. Total bilirubin above roughly 2.0 mg/dL with a disproportionate rise in the direct (conjugated) fraction is an obstructive or leak pattern — exactly what a bile duct injury produces. A predominantly indirect pattern suggests hemolysis or Gilbert's syndrome; a mixed pattern suggests hepatocellular injury. The fractionation is a widely available, inexpensive test and there is no defensible reason to omit it in a jaundiced post-operative patient.

Alkaline phosphatase and GGT rise together in obstructive or leak patterns. A rise in alkaline phosphatase without GGT elevation points away from biliary causes (bone disease, pregnancy). AST and ALT typically show a more modest elevation in pure obstruction but can rise sharply when significant hepatocellular injury is superimposed — for example, in late-stage cholangitis. Trending these values over 24-48 hours provides useful information about whether the process is progressive or stabilizing.

White blood cell count above 12,000/μL, with or without a left shift, in the presence of jaundice and right-upper-quadrant pain, is strongly suggestive of ascending cholangitis and should prompt sepsis-protocol management pending imaging. C-reactive protein and procalcitonin are sometimes added as adjunct inflammatory markers. None of this is expensive or esoteric — all of it is available at any community hospital — and the documented failure to order liver function tests in a jaundiced post-operative patient is frequently the first line in a delayed-diagnosis malpractice chronology.

Imaging is where diagnosis happens. In a jaundiced post-cholecystectomy patient, imaging should be ordered on the first clinical visit — ideally within hours of presentation if the patient is in the emergency department. The hierarchy of studies follows a predictable order.

Right-upper-quadrant ultrasound is the first-line study in most centers. It is fast, bedside-available, and non-invasive. It identifies intrahepatic biliary duct dilation (a sign of distal obstruction), free or loculated fluid in the perihepatic space (suggestive of a biloma or bile leak), and residual gallbladder fossa collections. Ultrasound sensitivity for stones in the common bile duct itself is modest — the duct can be difficult to visualize due to overlying bowel gas — but sensitivity for intrahepatic dilation is high.

CT scan of the abdomen and pelvis with contrast is the next step and is often the first study ordered in the emergency department setting because it broadens the differential to abscess, perforation, hemoperitoneum, and tumor. CT identifies bilomas, free fluid, abscesses, and gross biliary dilation reliably. Its sensitivity for small leaks and precise injury localization is lower than MRCP, but in the acute setting CT is often the pragmatic choice.

MRCP — magnetic resonance cholangiopancreatography — is the definitive non-invasive map of the biliary tree. It identifies the level and type of obstruction, shows leaks, and guides surgical planning with high accuracy. In a jaundiced post-operative patient where the bile duct is under suspicion, MRCP is generally considered the gold standard non-invasive study and is appropriate within 24-48 hours of presentation.

HIDA scanning (hepatobiliary iminodiacetic acid) confirms an active leak by tracking radiotracer passage from liver to gut. Extraluminal tracer confirms bile escape into the peritoneum and is highly specific. HIDA is particularly useful when imaging is ambiguous, when a small leak is suspected but not yet visible, or when a drain fluid bilirubin assay is positive but the source is not clear on anatomic imaging.

Across these modalities, the recurring failure mode in malpractice review is not the unavailability of the tests but the documented decision not to order them. Ultrasound, CT, and MRCP are available at every hospital in the United States; HIDA and ERCP are available at every medium-to-large center. When a jaundiced post-operative patient is discharged without imaging, that discharge is the documented breach.

ERCP — endoscopic retrograde cholangiopancreatography — is the procedure that bridges diagnosis and treatment for most post-cholecystectomy biliary problems. A gastroenterologist passes a side-viewing endoscope through the mouth, esophagus, and stomach into the duodenum, identifies the ampulla of Vater, and cannulates the biliary tree to inject contrast. The resulting cholangiogram maps leaks, strictures, retained stones, and the anatomy of any injury.

Crucially, ERCP is therapeutic as well as diagnostic. Retained stones can be extracted with a balloon or basket. Bile leaks can be stented — a plastic stent placed across the leak point diverts bile through the ampulla and away from the injury, allowing the duct to heal over several weeks. Strictures can be dilated with a balloon and stented for maintenance. For Strasberg Type A, B, C, and D injuries — which involve leaks or partial injuries rather than complete transections — ERCP is often the definitive treatment and avoids major abdominal surgery.

ERCP has limits. It cannot bridge a complete transection of the bile duct — when the duct is cut in two, the ends retract and the endoscopic approach cannot cannulate both ends. Complete transections (Strasberg Types E1-E5) require surgical reconstruction. The standard of care is Roux-en-Y hepaticojejunostomy, in which a loop of jejunum is brought up to the proximal bile duct and anastomosed directly. This is major abdominal surgery with significant recovery time and lifelong implications: biliary stent surveillance, recurrent cholangitis risk, and in some patients late development of biliary cirrhosis.

The distinction between an injury manageable by ERCP and an injury requiring hepaticojejunostomy drives much of the prognosis conversation. Injuries recognized early — within the first seventy-two hours — are more often manageable with stenting. Injuries recognized late — after two to three weeks of inflammation and retraction — almost always require open surgical reconstruction. That difference is a major driver of both clinical outcome and, when negligence drove the delay, the damages framework of the case.

Bile duct injuries are not a single entity. They range from a minor leak from a duct of Luschka on the gallbladder bed to a complete transection of a main hepatic duct, and the management and prognosis vary dramatically across that range. The Strasberg classification system, developed by Steven Strasberg, Michael Hertl, and Nathaniel Soper in a 1995 Journal of the American College of Surgeons paper, is the widely accepted framework for grading these injuries.

Type A is a leak from a minor duct — most commonly the cystic duct stump (slipped clip) or a duct of Luschka on the gallbladder bed. Type A leaks are typically managed with ERCP stenting and generally resolve without major surgery. Type B is occlusion of an aberrant right hepatic duct; Type C is transection of an aberrant right hepatic duct with an active leak. Types B and C can be subtle because the main bile duct is intact and serum bilirubin may not rise significantly. Type D is a lateral (partial) injury to the main bile duct — manageable with ERCP stenting or, in some cases, primary repair.

Types E1 through E5 involve the main bile duct and are graded by the level of injury relative to the hepatic duct confluence. E1 is a transection more than 2 cm from the confluence. E2 is within 2 cm. E3 is at the confluence but with continuity between the right and left ducts preserved. E4 is at the confluence with loss of continuity — the right and left ducts are separate. E5 involves an aberrant right hepatic duct in addition to the main bile duct. Types E1-E5 virtually always require Roux-en-Y hepaticojejunostomy, and outcomes vary with the level of the injury — proximal injuries (E3, E4, E5) carry higher long-term complication rates.

The Strasberg type drives the management plan, the prognosis, and a major portion of the malpractice damages analysis. A case where a Type A leak — manageable with a plastic stent and resolvable in weeks — was missed for two months and is now a Type E2 injury requiring hepaticojejunostomy represents a documented harm attributable to the delay, and the measurement of that delta is a core part of case evaluation. The Strasberg framework and our approach to these injuries is covered in more depth on the common bile duct injury page.

A bile duct injury alone is not automatic malpractice. The injury rate for laparoscopic cholecystectomy sits in roughly the 0.3-0.6% range across most published series — a small number that nonetheless represents thousands of patients each year. The legal question is not whether the injury happened; it is whether the operation breached the accepted standard of care (for example, failure to achieve the critical view of safety) and whether post-operative management missed the opportunity for early recognition.

Delayed recognition of post-operative jaundice is the single most common inflection point in these cases. When a jaundiced post-op patient presents, is sent home without imaging, returns days later worse, is sent home again, and eventually presents in septic shock — that chronology, documented in emergency department notes, clinic notes, and call logs, is the evidence of negligent management. The window from first presentation to eventual correct diagnosis often determines whether the patient's ultimate management was an ERCP stent or a major reconstructive surgery, and that distinction drives the damages calculation. The parallel signals — particularly post-op fever that was dismissed as viral — appear in the same chronology and should be read together; the full symptoms timeline lays out the arc.

State laws vary meaningfully on how bile duct injury cases proceed. Pre-suit requirements, expert affidavit rules, statute of limitations, discovery-rule provisions, and damages frameworks all shift by jurisdiction. Some states apply absolute statutes of repose that bar claims after a fixed number of years regardless of when the injury is discovered; others apply discovery rules that start the clock at the point of reasonable discovery. Damages caps — where they exist — often do not apply in cases of egregious harm or where the cap has been struck down by state supreme courts. Every case requires review by counsel licensed in the jurisdiction where the surgery occurred.

The practical framework at intake is to pull the complete operative record, the post-operative chart, every emergency department visit, every call log, and the imaging and lab results as they existed at each point. That contemporaneous record is what a medical expert reviews to form the opinion on breach and causation. For a fuller framework on these cases — including the critical view of safety, Strasberg grading, and the documentation we request at intake — see the common bile duct injury page. For the broader post-operative symptom framework of which jaundice is one component, see the bile duct injury symptoms hub.